- Home
- ARBB vs BCDA Comparison
ARBB vs BCDA Comparison
Compare ARBB & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- BCDA
- Stock Information
- Founded
- ARBB 1997
- BCDA N/A
- Country
- ARBB Singapore
- BCDA United States
- Employees
- ARBB N/A
- BCDA N/A
- Industry
- ARBB EDP Services
- BCDA Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- BCDA Health Care
- Exchange
- ARBB Nasdaq
- BCDA Nasdaq
- Market Cap
- ARBB 11.9M
- BCDA 11.0M
- IPO Year
- ARBB 2023
- BCDA N/A
- Fundamental
- Price
- ARBB $6.45
- BCDA $2.01
- Analyst Decision
- ARBB Strong Buy
- BCDA Strong Buy
- Analyst Count
- ARBB 1
- BCDA 1
- Target Price
- ARBB $20.00
- BCDA $25.00
- AVG Volume (30 Days)
- ARBB 13.5K
- BCDA 54.0K
- Earning Date
- ARBB 07-11-2025
- BCDA 08-12-2025
- Dividend Yield
- ARBB N/A
- BCDA N/A
- EPS Growth
- ARBB N/A
- BCDA N/A
- EPS
- ARBB N/A
- BCDA N/A
- Revenue
- ARBB $24,425,491.00
- BCDA $3,000.00
- Revenue This Year
- ARBB N/A
- BCDA N/A
- Revenue Next Year
- ARBB N/A
- BCDA N/A
- P/E Ratio
- ARBB N/A
- BCDA N/A
- Revenue Growth
- ARBB N/A
- BCDA N/A
- 52 Week Low
- ARBB $3.22
- BCDA $1.63
- 52 Week High
- ARBB $18.60
- BCDA $4.66
- Technical
- Relative Strength Index (RSI)
- ARBB 43.40
- BCDA 42.37
- Support Level
- ARBB $6.49
- BCDA $1.98
- Resistance Level
- ARBB $7.46
- BCDA $2.45
- Average True Range (ATR)
- ARBB 0.54
- BCDA 0.17
- MACD
- ARBB 0.14
- BCDA -0.01
- Stochastic Oscillator
- ARBB 62.13
- BCDA 10.00
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).